Category: Leica Microsystems

Posted on

FDA Clears Leica Microsystems AR Visualization Solution GLOW800

Leica Microsystems have received 510(k) clearance from the US Food and Drug Administration (FDA) to market its augmented reality (AR) GLOW800 surgical fluorescence for vascular neurosurgery. In combination with Indocyanine Green (IGG), GLOW800 provides surgeons with the means to observe cerebral anatomy in natural colour, augmented by real-time vascular flow in a single image, with full depth perception. This AR solution allows surgeons with a complete view of anatomy and physiology to support crucial decisions and actions during vascular neurosurgery.

GLOW800

“For the past decade Leica Microsystems has been pioneering new fluorescence imaging technologies in partnership with surgeons to advance surgical practices,” Explains Markus Lusser, President of Leica Microsystems. “GLOW800 and future modalities based on the GLOW AR platform will allow surgeons to perform life-changing neurosurgical interventions with the confidence that they have the best possible visual information right in the field of view.”

First revealed back in October of last year, the GLOW800 AR fluorescence is the first of many imaging modalities that will be based on the GLOW AR platform from Leica Microsystems. The GLOW AR modalities can be fully integrated into the ARveo digital AR microscope which launched earlier this year. From here and following the FDA 510(k) clearance of the GLOW800, ARveo customers in the United States will be able to experience the full advantages of AR visualization in the operating room which will dynamically change up how surgeons carry out operations.

“Leica Microsystems is a company that works closely with neurosurgeons to bring new technologies to market that really respond to our needs,” Adds Cleopatra Charalampaki, Professor of Neurosurgery, Cologne Medical Center, Germany. “GLOW800 AR is an exciting new approach which provides a totally new view during vascular neurosurgery. I have excellent spatial orientation and I am impressed with the crisp delineation of vessels. I believe GLOW800 AR fluorescence will have a significant impact on surgical outcomes in the future.”

VRFocus will be sure to continue to bring you all the latest on all things virtual reality (VR) and AR in the future, along with all the developments on Leica Microsystems, so stay tuned for more.

Posted on

Augmented Reality for Vascular Neurosurgery

Neurosurgery is one of the most complex and difficult specialisations that surgeons can take. With this particular area, having accurate information on what needs to be operated on. A new augmented reality (AR) system called GLOW allows surgeons to get a better view.

In vascular neurosurgery, it is often necessary to use a highlighting agent such as Indocyanine Green, a fluorescent substance that allows the vascular blood flow to be seen using a near-infrared camera. However, this means surgeons must divide their time between the camera view and the view through a normal optical microscope. The AR GLOW system allows the highlighted blood flow view to be combined with the optical image.

“For the past decade Leica Microsystems has been pioneering new fluorescence imaging technologies in partnership with surgeons to advance surgical practices,” says Markus Lusser, President of Leica Microsystems. “GLOW800 and future modalities based on the GLOW AR platform will allow surgeons to perform life-changing neurosurgical interventions with the confidence that they have the best possible visual information right in the field of view.”

“Leica Microsystems is a company that works closely with neurosurgeons to bring new technologies to the market that really respond to our needs,” says Cleopatra Charalampaki, Professor of Neurosurgery, Cologne Medical Center, Germany. “GLOW800 AR is an exciting new approach which provides a totally new view during vascular neurosurgery. I have excellent spatial orientation and I am impressed with the crisp delineation of vessels. I believe GLOW800 AR fluorescence will have a significant impact on surgical outcomes in the future.”

The GLOW AR system has not yet been cleared for medical use, but visitors to the Congress of Neurological Surgeons will be able to see demonstrations of the technology.

VRFocus will continue to report on new developments in VR and AR.